Ropes Wealth Advisors’s Arcus Biosciences RCUS Stock Holding History

Ropes Wealth Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20	Closed	-$1K	–	659
2020 Q4	$1K	Buy	+20	New	+$484	﹤0.01%	762

Other funds holding RCUS

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Ropes Wealth Advisors's RCUS Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Arcus Biosciences (RCUS) in Q1 2021, closing a stake of 20 shares — an estimated $1K sold.

Ropes Wealth Advisors first reported a position in RCUS in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 148 funds tracked by Wall St. Rank hold RCUS as of Q1 2021.

Ropes Wealth Advisors reported no remaining Arcus Biosciences position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 20 Arcus Biosciences shares in Q1 2021, an estimated $1K.
Ropes Wealth Advisors first reported a position in Arcus Biosciences in Q4 2020 and held it in 1 quarter.
Ropes Wealth Advisors's Arcus Biosciences position peaked at $1K in Q4 2020.
148 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.